ForumIAS LATEST
- 16 June | Failed Before Success: AIR 295 Reveals His UPSC Journey | Click Here to Watch →
- 17 June | How to Write High-Scoring Answers in Hindi Literature Optional | Click Here to Watch →
- 18 June | From Setback to Success: Bhavika Chopra's Rise to AIR 25 | Click Here to Watch →
- 19 June | The Rankforge Challenge (FRC/Tapasya): Truth About UPSC & Coaching by Ayush Sinha | Click Here to Watch →
- 20 June | 150+ Cleared UPSC Prelims from Naugaon, Alwar | The FRC Tapasya Success Story | Click Here to Watch →
News: The Endocrine Society has renamed Polycystic Ovary Syndrome (PCOS) as Polyendocrine Metabolic Ovarian Syndrome (PMOS) through a global medical consensus.
About Polyendocrine Metabolic Ovarian Syndrome (PMOS)
- PMOS is a hormonal and metabolic disorder that affects endocrine functions, metabolism, ovulation and overall women’s health.
- Key Aspects of PMOS:
- Hormonal and Metabolic Disorder: PMOS affects multiple hormone systems and is strongly linked with insulin resistance, obesity, diabetes risk and metabolic complications.
- Major Symptoms: Common symptoms include irregular or absent periods, excess androgen hormones, acne, facial hair growth, weight gain, difficulty losing weight and fertility challenges.
- Broader Health Impact: PMOS increases long-term risks of Type 2 diabetes, hypertension, heart disease, fatty liver disease, sleep disorders, depression and anxiety.
- Reproductive and Psychological Effects: The condition may lead to ovulatory dysfunction, infertility, pregnancy complications, anxiety, depression and poor quality of life.
- Diagnosis Challenges: Experts noted that PMOS is often underdiagnosed because symptoms vary widely and are frequently treated as cosmetic or lifestyle-related concerns.
- Indian Scenario: India is witnessing a rise in PMOS cases, especially among adolescents and young urban women, with studies showing prevalence ranging from 3.7% to over 22%.
- New Name Signifies:
- Earlier Name Was Misleading: The earlier term “Polycystic Ovary Syndrome” mainly focused on ovarian cysts, even though many women with the condition do not actually develop ovarian cysts.
- New Name Reflect: The new term “Polyendocrine Metabolic Ovarian Syndrome” was introduced to reflect the multisystem nature of the disorder, which affects hormone systems, metabolism, ovulation, reproductive health and long-term overall health.
